FY2025 EPS Estimates for RCUS Boosted by Cantor Fitzgerald
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Research analysts at Cantor Fitzgerald upped their FY2025 earnings per share (EPS) estimates for shares of Arcus Biosciences in a research note issued on Tuesday, March 11th. Cantor Fitzgerald analyst L. Watsek now forecasts that the company will earn ($3.65) per share for the year, up from […]
